Víctor Moreno

Empresa Municipal de Transportes de Madrid

Also affiliated with Hospital Universitario Fundación Jiménez Díaz

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study”.

Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study

International Journal of Cancer(2021)10.1002/ijc.33861

N/A

1.9DataRank · unranked

62 citations

Jean‐Yves Blay, Irene García, Johann S. De Bono, Christophe Le Tourneau, Víctor Moreno +25 more

Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion–Positive Lung Cancers

JCO Precision Oncology(2022)10.1200/po.21.00418

N/A

1.9DataRank · unranked

87 citations

Daniel S.W. Tan, Ulrik Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D. Patel +10 more

Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas

Cancer(2023)10.1002/cncr.35036

N/A

0.937DataRank · unranked

25 citations

Lin Shen, David S. Hong, Ray McDermott, Vicki L. Keedy, Michela Casanova +19 more

Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study

ESMO Open(2022)10.1016/j.esmoop.2022.100571

N/A

0.427DataRank · unranked

11 citations

Barbara Pistilli, Irene Braña, Geoffrey I. Shapiro, José Trigo, Víctor Moreno +13 more

Germline genetic regulation of the colorectal tumor immune microenvironment

BMC Genomics(2024)10.1186/s12864-024-10295-1

N/A

0.312DataRank · unranked

7 citations

Ya-Yu Tsai, Joseph D. Bonner, Rebeca Sanz‐Pamplona, Amit D. Joshi, Tomotaka Ugai +20 more

794 Safety and efficacy results from a phase 1/1b study of intratumoral MK-4621, a retinoic acid-inducible gene I (RIG-I) agonist, plus intravenous pembrolizumab in patients with advanced solid tumors

(2020)10.1136/jitc-2020-sitc2020.0794

N/A

0DataRank · unranked

4 citations

Caroline Gaudy‐Marqueste, Martin Wermke, Antoîne Italiano, Emanuela Romano, Aurélien Marabelle +7 more

Using gene-environment interactions to explore pathways for colorectal cancer risk

EBioMedicine(2025)10.1016/j.ebiom.2025.105964

N/A

0DataRank · unranked

3 citations

Ren Yu, Andre E. Kim, Georgios Markozannes, Neil Murphy, Demetrius Albanes +58 more